Long range planning is one of the most consequential — and most contested — processes in biotech and pharma finance. The hard part usually isn't the math; it's the decisions: which assumptions to trust, how to model uncertainty, when to override a forecast, and how to get finance, clinical, and commercial teams to agree on a number everyone can stand behind.
In this session, join Condor alongside finance leaders who've lived through the shift firsthand for a candid, moderated conversation about where LRP breaks down today, what's actually possible with generic LLMs like ChatGPT and Copilot, and what changes once purpose-built AI enters the picture.
Featured Panelists:
Roy Gonzales, Fractional CFO, Clinical-Stage Biotech
Terrence Allotta, Senior Director, R&D Finance, ACADIA Pharmaceuticals
The discussion will be moderated by Jeff Jahnke, Head of Customer Success at Condor.
Expect real tradeoffs and no scripted pitch — just practitioners talking honestly about what worked, what didn't, and what they'd do differently. We'll run a live show-and-tell of both approaches, take questions throughout, and send everyone home with a prompt library to try with their own teams.
Stick around after for cocktails and to keep the conversation going.